ASPARAGINE SYNTHETASE DEFICIENCY
|
0.730 |
Biomarker
|
disease |
CLINGEN |
Effect of inbreeding on intellectual disability revisited by trio sequencing.
|
30315573 |
2019 |
ASPARAGINE SYNTHETASE DEFICIENCY
|
0.730 |
Biomarker
|
disease |
CLINGEN |
Clinical whole exome sequencing from dried blood spot identifies novel genetic defect underlying asparagine synthetase deficiency.
|
29375865 |
2018 |
ASPARAGINE SYNTHETASE DEFICIENCY
|
0.730 |
Biomarker
|
disease |
CLINGEN |
Asparagine Synthetase Deficiency (ASD) is a recently described inborn error of metabolism caused by bi-allelic pathogenic variants in the asparagine synthetase (ASNS) gene.
|
29279279 |
2018 |
ASPARAGINE SYNTHETASE DEFICIENCY
|
0.730 |
Biomarker
|
disease |
CLINGEN |
Novel Mutations in the Asparagine Synthetase Gene (ASNS) Associated With Microcephaly.
|
30057589 |
2018 |
ASPARAGINE SYNTHETASE DEFICIENCY
|
0.730 |
Biomarker
|
disease |
CLINGEN |
Report of four novel variants in ASNS causing asparagine synthetase deficiency and review of literature.
|
29405484 |
2018 |
ASPARAGINE SYNTHETASE DEFICIENCY
|
0.730 |
Biomarker
|
disease |
CLINGEN |
Increasing the sensitivity of clinical exome sequencing through improved filtration strategy.
|
27711071 |
2017 |
ASPARAGINE SYNTHETASE DEFICIENCY
|
0.730 |
Biomarker
|
disease |
CLINGEN |
The first report of Japanese patients with asparagine synthetase deficiency.
|
27743885 |
2017 |
ASPARAGINE SYNTHETASE DEFICIENCY
|
0.730 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
To date, seven families and seven missense mutations in the ASNSD disease causing gene, ASNS, have been published.
|
27469131 |
2017 |
ASPARAGINE SYNTHETASE DEFICIENCY
|
0.730 |
Biomarker
|
disease |
CLINGEN |
To date, seven families and seven missense mutations in the ASNSD disease causing gene, ASNS, have been published.
|
27469131 |
2017 |
ASPARAGINE SYNTHETASE DEFICIENCY
|
0.730 |
Biomarker
|
disease |
CLINGEN |
Asparagine synthetase deficiency is a rare inborn error of metabolism caused by a defect in ASNS, a gene encoding asparagine synthetase.
|
28776279 |
2017 |
ASPARAGINE SYNTHETASE DEFICIENCY
|
0.730 |
Biomarker
|
disease |
CLINGEN |
Hyperekplexia, microcephaly and simplified gyral pattern caused by novel ASNS mutations, case report.
|
27422383 |
2016 |
ASPARAGINE SYNTHETASE DEFICIENCY
|
0.730 |
Biomarker
|
disease |
CLINGEN |
Mosaic parental germline mutations causing recurrent forms of malformations of cortical development.
|
26395554 |
2016 |
ASPARAGINE SYNTHETASE DEFICIENCY
|
0.730 |
Biomarker
|
disease |
CLINGEN |
Asparagine synthetase deficiency detected by whole exome sequencing causes congenital microcephaly, epileptic encephalopathy and psychomotor delay.
|
25227173 |
2015 |
ASPARAGINE SYNTHETASE DEFICIENCY
|
0.730 |
Biomarker
|
disease |
CLINGEN |
Asparagine Synthetase Deficiency: New Inborn Errors of Metabolism.
|
25663424 |
2015 |
ASPARAGINE SYNTHETASE DEFICIENCY
|
0.730 |
Biomarker
|
disease |
CLINGEN |
Asparagine Synthetase Deficiency causes reduced proliferation of cells under conditions of limited asparagine.
|
26318253 |
2015 |
ASPARAGINE SYNTHETASE DEFICIENCY
|
0.730 |
GeneticVariation
|
disease |
UNIPROT |
Deficiency of asparagine synthetase causes congenital microcephaly and a progressive form of encephalopathy.
|
24139043 |
2013 |
ASPARAGINE SYNTHETASE DEFICIENCY
|
0.730 |
Biomarker
|
disease |
CLINGEN |
Deficiency of asparagine synthetase causes congenital microcephaly and a progressive form of encephalopathy.
|
24139043 |
2013 |
ASPARAGINE SYNTHETASE DEFICIENCY
|
0.730 |
GermlineCausalMutation
|
disease |
ORPHANET |
Deficiency of asparagine synthetase causes congenital microcephaly and a progressive form of encephalopathy.
|
24139043 |
2013 |
ASPARAGINE SYNTHETASE DEFICIENCY
|
0.730 |
Biomarker
|
disease |
CLINGEN |
Asparagine biosynthesis by the Novikoff Hepatoma isolation, purification, property, and mechanism studies of the enzyme system.
|
4295091 |
1968 |
ASPARAGINE SYNTHETASE DEFICIENCY
|
0.730 |
Biomarker
|
disease |
CTD_human |
|
|
|
ASPARAGINE SYNTHETASE DEFICIENCY
|
0.730 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Malignant neoplasm of liver
|
0.510 |
Biomarker
|
disease |
CTD_human |
Discriminating between adaptive and carcinogenic liver hypertrophy in rat studies using logistic ridge regression analysis of toxicogenomic data: The mode of action and predictive models.
|
28108177 |
2017 |
Liver neoplasms
|
0.500 |
Biomarker
|
group |
CTD_human |
Discriminating between adaptive and carcinogenic liver hypertrophy in rat studies using logistic ridge regression analysis of toxicogenomic data: The mode of action and predictive models.
|
28108177 |
2017 |
Liver Cirrhosis, Experimental
|
0.300 |
Biomarker
|
disease |
CTD_human |
Systems level analysis and identification of pathways and networks associated with liver fibrosis.
|
25380136 |
2014 |
Lipoidosis
|
0.300 |
Biomarker
|
disease |
CTD_human |
Determination of phospholipidosis potential based on gene expression analysis in HepG2 cells.
|
17175557 |
2007 |